Cwm LLC Has $143,000 Stock Holdings in Masimo Co. (NASDAQ:MASI)

Cwm LLC trimmed its stake in shares of Masimo Co. (NASDAQ:MASI) by 8.0% during the third quarter, Holdings Channel reports. The firm owned 1,070 shares of the medical equipment provider’s stock after selling 93 shares during the period. Cwm LLC’s holdings in Masimo were worth $143,000 at the end of the most recent reporting period.

Other large investors also recently modified their holdings of the company. Edgestream Partners L.P. acquired a new position in Masimo during the second quarter worth $645,000. Simplify Asset Management Inc. grew its stake in Masimo by 120.4% during the second quarter. Simplify Asset Management Inc. now owns 21,670 shares of the medical equipment provider’s stock worth $2,729,000 after buying an additional 11,838 shares during the last quarter. State Board of Administration of Florida Retirement System increased its holdings in shares of Masimo by 11.6% during the first quarter. State Board of Administration of Florida Retirement System now owns 54,839 shares of the medical equipment provider’s stock worth $8,053,000 after buying an additional 5,688 shares in the last quarter. Advisors Asset Management Inc. increased its holdings in shares of Masimo by 32.1% during the first quarter. Advisors Asset Management Inc. now owns 9,009 shares of the medical equipment provider’s stock worth $1,323,000 after buying an additional 2,187 shares in the last quarter. Finally, Mirae Asset Global Investments Co. Ltd. raised its stake in shares of Masimo by 33.9% in the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 42,196 shares of the medical equipment provider’s stock valued at $6,196,000 after acquiring an additional 10,683 shares during the last quarter. 85.96% of the stock is currently owned by institutional investors.

Masimo Price Performance

Masimo stock opened at $140.74 on Friday. The stock has a market cap of $7.48 billion, a price-to-earnings ratio of 95.74 and a beta of 0.99. Masimo Co. has a 12-month low of $75.36 and a 12-month high of $153.93. The company has a quick ratio of 1.15, a current ratio of 2.09 and a debt-to-equity ratio of 0.55. The business’s 50-day simple moving average is $127.05 and its 200 day simple moving average is $125.29.

Masimo (NASDAQ:MASI) last announced its quarterly earnings data on Tuesday, August 6th. The medical equipment provider reported $0.86 earnings per share for the quarter, beating the consensus estimate of $0.77 by $0.09. Masimo had a net margin of 3.94% and a return on equity of 14.07%. The business had revenue of $496.30 million for the quarter, compared to analyst estimates of $493.92 million. During the same period in the prior year, the business posted $0.62 earnings per share. Masimo’s revenue was up 9.0% compared to the same quarter last year. As a group, research analysts anticipate that Masimo Co. will post 3.88 earnings per share for the current year.

Analysts Set New Price Targets

A number of research firms recently weighed in on MASI. BTIG Research raised their price target on Masimo from $166.00 to $170.00 and gave the company a “buy” rating in a report on Monday, October 14th. Piper Sandler reiterated an “overweight” rating on shares of Masimo in a research report on Friday, October 18th. Finally, Needham & Company LLC restated a “hold” rating on shares of Masimo in a research report on Friday, September 20th. Four equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $145.33.

About Masimo

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.